Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Texas MPN Workshop 2020 | Inflammation as a predisposing factor to MPN development

Angela Fleischman • 19 Aug 2020
Texas MPN Workshop 2020
Myeloproliferative Neoplasms

Angela Fleischman, MD, UCI Health, Orange County, CA, discusses the role of inflammation as a predisposing factor to acquiring myeloproliferative neoplasms (MPN), as well as its role in diagnosis, prognosis and disease monitoring. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Angela Fleischman

The MPN microenvironment
Angela Fleischman • 24 Nov 2022
Inflammation, dietary factors, and the MPN microenvironment
Angela Fleischman • 10 Nov 2022
6:37
Drivers of progression in MPNs and the importance of early intervention
Andrew Kuykendall et al. • 26 Aug 2022
2:30
Diet as an approach to reduce inflammation in patients with MPNs
Angela Fleischman • 18 Aug 2021

Related Videos

2:05
Donor lymphocyte infusion for relapsed myelofibrosis in the post-alloSCT setting
Alex Rampotas • 16 Apr 2024
2:52
JAK inhibitor combination therapy for the treatment of myelofibrosis
Ruben Mesa • 9 Dec 2023
1:30
XPORT-MF-034: selinexor + ruxolitinib combination therapy for MF
John Mascarenhas • 10 Dec 2023
1:38
Pelabresib plus ruxolitinib for the treatment of intermediate- and high-risk myelofibrosis
John Mascarenhas • 10 Dec 2023
The content of VJHemOnc is intended for healthcare professionals